Health X Platform Ltd

- There is no explicit mention of any current or immediate plans for fundraising through debt or equity in the Q3 FY24 earnings call. - The management emphasized focusing on cost-cutting, operational improvements, and achieving positive EBITDA next year. - Cash utilization plans are contingent upon completing the simplification of the corporate structure, which is currently delaying liquidity deployment. - Cash is largely held in a subsidiary, making direct utilization tax-inefficient until simplification is done. - No direct reference to new debt or equity fundraising was made; management is prioritizing sustainability and organic growth via RetailerShakti. - The company expects to work on structural simplification before any cash deployment or external financing decisions are made.

- No significant warehouse expansion plans in the next 1-2 quarters; current seven warehouses sufficient for planned growth (Page 14). - Capex requirements are minimal, with a focus on cost efficiency and stability (Page 15). - No plans to start offline presence despite having no agreement restricting it; focus remains on RetailerShakti digital model (Page 15). - Investment and growth focus predominantly on RetailerShakti platform and technology enhancement (Page 4, 5). - Exploring product credit offerings to retailers in collaboration with FinTechs, NBFCs, and banks, which may be a future strategic investment area (Page 14). - No detailed guidance given on revenue or profitability projections or specific capital expenditure for future quarters (Page 14).

- RetailerShakti is identified as the clear growth engine for SastaSundar, expected to deliver substantial growth going forward. - The company is targeting around 15,000 actively transacting retailers by the end of the fiscal year, up from about 11,100 currently. - Retailer additions are ongoing, including expansion into newer geographies like the northeast, with approximately 1,000 retailers being added quarterly. - Growth derives both from acquiring new retailers and increasing wallet share of existing retailers. - Healthbuddy growth has slowed and is expected to remain flat or modest; management focus has shifted towards RetailerShakti. - Industry discounting has normalized, leading to sustainable but slower e-pharmacy growth (20%-30% year-on-year). - Revenue for RetailerShakti grew ~20% quarter-on-quarter recently, with operational profitability expected soon. - No formal revenue guidance is provided, but management is confident in the growth prospects of the RetailerShakti platform.

- EBITDA expected to turn positive next year due to cost-cutting and growth in RetailerShakti. - Operational cash positive status anticipated in the next fiscal year. - Company targeting INR500 crores revenue run rate soon, up from current INR360 crores. - RetailerShakti identified as the primary growth engine over Healthbuddy/Flipkart tie-up. - Gross margin improvement expected over 2 years, with potential 3%-4% increase via higher procurement margin. - Short-term gross margin around 10% not achievable, but sustainable growth prioritized over fast expansion. - Cost reductions underway, especially in operational expenses related to RetailerShakti. - Simplification of corporate structure pending, expected to aid better liquidity utilization and shareholder returns. - No formal revenue or profitability guidance provided due to market uncertainties.

- The transcript does not explicitly mention the current or expected order book or pending orders. - The company has highlighted growth in its Retailer Shakti business with over 11,100 unique retailers placing orders in the recent quarter, up from approximately 9,680 in the previous quarter. - Average invoice value for Retailer Shakti was around INR 1.33 lakhs in the recent quarter, up from INR 1.27 lakhs earlier. - The company is expanding into new geographies, including northeast India, indicating expectation of increasing orders. - There is no specific quantitative data shared on order backlog or pending orders. - Management focuses on strengthening Retailer Shakti and addressing challenges in Healthbuddy supply chain, indicating ongoing order fulfillment. - No forward-looking guidance on orders or revenue is provided due to industry uncertainties.